AVPR2 and Parkinson disease: More importantly, in this study, the rAAV was injected at the same day when MPTP was administrated, which made the peak expression of rAAV-directed NDI1 (day 35–42) occur after the appearance of MPTP-induced PD symptoms (day 1–35).